1. Home
  2. ORGO vs QUIK Comparison

ORGO vs QUIK Comparison

Compare ORGO & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

BUY

Current Price

$1.03

Market Cap

166.0M

Sector

Health Care

ML Signal

BUY

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$8.83

Market Cap

196.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORGO
QUIK
Founded
1985
1988
Country
United States
United States
Employees
N/A
51
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
166.0M
196.7M
IPO Year
2016
1997

Fundamental Metrics

Financial Performance
Metric
ORGO
QUIK
Price
$1.03
$8.83
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
$2.00
★ $23.00
AVG Volume (30 Days)
★ 750.4K
159.7K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1600.00
N/A
EPS
N/A
★ N/A
Revenue
★ $564,169,000.00
$20,112,000.00
Revenue This Year
N/A
$73.33
Revenue Next Year
$37.55
$16.92
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 17.04
N/A
52 Week Low
$0.93
$5.28
52 Week High
$7.08
$24.33

Technical Indicators

Market Signals
Indicator
ORGO
QUIK
Relative Strength Index (RSI) 26.71 30.07
Support Level N/A $8.72
Resistance Level $2.57 $9.27
Average True Range (ATR) 0.08 0.43
MACD -0.01 -0.16
Stochastic Oscillator 23.06 0.98

Price Performance

Historical Comparison
ORGO
QUIK

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

Share on Social Networks: